Literature DB >> 10338527

Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.

L E Bermudez1, M Petrofsky.   

Abstract

The role of CD8(+) T cells was evaluated in a mouse model of disseminated Mycobacterium avium infection. C57BL/6J and C57BL/6Jbeta2-/- (beta2-/-) mice were infected intravenously, and the number of viable bacteria in each liver and spleen was determined. No significant difference between the number of bacteria in the two strains of mice was observed at 2, 4, 6, and 8 weeks after infection. Histopathological examination of granulomas from C57BL/6J and beta2-/- mice did not show any difference either in the number of organisms per granuloma or in the size of the granulomas. Investigation of the cytokine profile in the spleen demonstrated that the beta2-/- strain of mice produced a significantly lower amount of gamma interferon at 8 weeks after infection and significantly increased concentrations of tumor necrosis factor alpha compared with that from the wild-type mouse. Interleukin-12 and transforming growth factor beta1 levels did not differ between the two strains of mice at 2, 4, 6, and 8 weeks. Although previous work had found that host response against Mycobacterium tuberculosis involves major histocompatibility complex class I-restricted T cells, our results indicate that chronic deficiency of CD8(+) T cells does not lead to a different expression of the disease and that if CD8(+) T cells are involved in the host response, their function can be assumed by other immune cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338527      PMCID: PMC96628          DOI: 10.1128/IAI.67.6.3108-3111.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.

Authors:  N Azouaou; M Petrofsky; L S Young; L E Bermudez
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase.

Authors:  S Sturgill-Koszycki; P H Schlesinger; P Chakraborty; P L Haddix; H L Collins; A K Fok; R D Allen; S L Gluck; J Heuser; D G Russell
Journal:  Science       Date:  1994-02-04       Impact factor: 47.728

4.  Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.

Authors:  L E Bermudez; M Wu; L S Young
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.

Authors:  B M Saunders; Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 6.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon.

Authors:  B M Saunders; C Cheers
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

9.  Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model.

Authors:  L E Bermudez; P Kolonoski; L S Young
Journal:  J Leukoc Biol       Date:  1990-02       Impact factor: 4.962

10.  Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.

Authors:  L E Bermudez; J Champsi
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  10 in total

1.  Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.

Authors:  E Martin; J A Triccas; A T Kamath; N Winter; W J Britton
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Generalized immunological decline during long-term experimental infection with Mycobacterium avium.

Authors:  Brad Gilbertson; Christina Cheers
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection.

Authors:  Brad Gilbertson; Susie Germano; Pauline Steele; Steven Turner; Barbara Fazekas de St Groth; Christina Cheers
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Interaction of Mycobacterium avium with human monocyte-derived dendritic cells.

Authors:  N Mohagheghpour; A van Vollenhoven; J Goodman; L E Bermudez
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?

Authors:  Rui Appelberg
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation.

Authors:  K G Mansfield; R S Veazey; A Hancock; A Carville; M Elliott; K C Lin; A A Lackner
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Non-major histocompatibility complex control of antibody isotype and Th1 versus Th2 cytokines during experimental infection of mice with Mycobacterium avium.

Authors:  V Nagabhushanam; C Cheers
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Increased susceptibility to Mycobacterium avium in hemochromatosis protein HFE-deficient mice.

Authors:  Sandra Gomes-Pereira; Pedro Nuno Rodrigues; Rui Appelberg; Maria Salomé Gomes
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

9.  Cellular immune response to pulmonary infections in HIV-infected individuals hospitalized with diverse grades of immunosuppression.

Authors:  M J Miguez-Burbano; D Ashkin; A Rodriguez; R Duncan; M Flores; B Acosta; N Quintero; A Pitchenik
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

10.  Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium.

Authors:  Nisha Kannan; Markus Haug; Magnus Steigedal; Trude Helen Flo
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.